Smartest Doc
Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the ‘Act when Mild’ Study
Applied Health Economics and Health Policy, 05/07/2012
Slof J – Compared with non–early treatment, a strategy of early treatment of acute migraine with almotriptan when pain is still mild is, with high probability, cost saving from the French societal perspective and can be considered cost effective from the public health system point of view.
